Prof. Stephan Ludwig, Ph.D. (Chair)
Co-inventor of the technology, globally renowned expert in influenza virus-cell interactions. Over 150 scientific publications and more than 10 patents.
Management experience in Life Science Industry (i.e Baxter). Track record of successful market entries and financing transactions.
Frans van Dalen
Project Management, QA/QP, R&D and RA experience of more than 25 years with regard to development of generics, biosimilars and NBEs. More than 25 patents.
Passionate entrepreneur in the field of innovation and building businesses who led investment rounds in several companies, and has invested for among others Wageningen Business Generator and Multifund. Board Member of Xenikos and Chairman of the GHI-Financials.
Observer on behalf of Hightech-Gründer-Fonds GmbH
Investment manager with founding and management experience in the Biotech Industry and strong background in the development of monoclonal antibodies for cancer treatment.